Cargando…
u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression
BACKGROUND: Multiple Myeloma (MM) is a B-cell malignancy in which clonal plasma cells progressively expand within the bone marrow (BM) as effect of complex interactions with extracellular matrix and a number of microenvironmental cells. Among these, cancer-associated fibroblasts (CAF) mediate crucia...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366111/ https://www.ncbi.nlm.nih.gov/pubmed/28340565 http://dx.doi.org/10.1186/s12885-017-3183-y |
_version_ | 1782517530439450624 |
---|---|
author | Ciavarella, S Laurenzana, A De Summa, S Pilato, B Chillà, A Lacalamita, R Minoia, C Margheri, F Iacobazzi, A Rana, A Merchionne, F Fibbi, G Del Rosso, M Guarini, A Tommasi, S Serratì, S |
author_facet | Ciavarella, S Laurenzana, A De Summa, S Pilato, B Chillà, A Lacalamita, R Minoia, C Margheri, F Iacobazzi, A Rana, A Merchionne, F Fibbi, G Del Rosso, M Guarini, A Tommasi, S Serratì, S |
author_sort | Ciavarella, S |
collection | PubMed |
description | BACKGROUND: Multiple Myeloma (MM) is a B-cell malignancy in which clonal plasma cells progressively expand within the bone marrow (BM) as effect of complex interactions with extracellular matrix and a number of microenvironmental cells. Among these, cancer-associated fibroblasts (CAF) mediate crucial reciprocal signals with MM cells and are associated to aggressive disease and poor prognosis. A large body of evidence emphasizes the role of the urokinase plasminogen activator (u-PA) and its receptor u-PAR in potentiating the invasion capacity of tumor plasma cells, but little is known about their role in the biology of MM CAF. In this study, we investigated the u-PA/u-PAR axis in MM-associated fibroblasts and explore additional mechanisms of tumor/stroma interplay in MM progression. METHODS: CAF were purified from total BM stromal fraction of 64 patients including monoclonal gammopathy of undetermined significance, asymptomatic and symptomatic MM, as well as MM in post-treatment remission. Flow cytometry, Real Time PCR and immunofluorescence were performed to investigate the u-PA/u-PAR system in relation to the level of activation of CAF at different stages of the disease. Moreover, proliferation and invasion assays coupled with silencing experiments were used to prove, at functional level, the function of u-PAR in CAF. RESULTS: We found higher activation level, along with increased expression of pro-invasive molecules, including u-PA, u-PAR and metalloproteinases, in CAF from patients with symptomatic MM compared to the others stages of the disease. Consistently, CAF from active MM as well as U266 cell line under the influence of medium conditioned by active MM CAF, display higher proliferative rate and invasion potential, which were significantly restrained by u-PAR gene expression inhibition. CONCLUSIONS: Our data suggest that the stimulation of u-PA/u-PAR system contributes to the activated phenotype and function of CAF during MM progression, providing a biological rationale for future targeted therapies against MM. |
format | Online Article Text |
id | pubmed-5366111 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53661112017-03-28 u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression Ciavarella, S Laurenzana, A De Summa, S Pilato, B Chillà, A Lacalamita, R Minoia, C Margheri, F Iacobazzi, A Rana, A Merchionne, F Fibbi, G Del Rosso, M Guarini, A Tommasi, S Serratì, S BMC Cancer Research Article BACKGROUND: Multiple Myeloma (MM) is a B-cell malignancy in which clonal plasma cells progressively expand within the bone marrow (BM) as effect of complex interactions with extracellular matrix and a number of microenvironmental cells. Among these, cancer-associated fibroblasts (CAF) mediate crucial reciprocal signals with MM cells and are associated to aggressive disease and poor prognosis. A large body of evidence emphasizes the role of the urokinase plasminogen activator (u-PA) and its receptor u-PAR in potentiating the invasion capacity of tumor plasma cells, but little is known about their role in the biology of MM CAF. In this study, we investigated the u-PA/u-PAR axis in MM-associated fibroblasts and explore additional mechanisms of tumor/stroma interplay in MM progression. METHODS: CAF were purified from total BM stromal fraction of 64 patients including monoclonal gammopathy of undetermined significance, asymptomatic and symptomatic MM, as well as MM in post-treatment remission. Flow cytometry, Real Time PCR and immunofluorescence were performed to investigate the u-PA/u-PAR system in relation to the level of activation of CAF at different stages of the disease. Moreover, proliferation and invasion assays coupled with silencing experiments were used to prove, at functional level, the function of u-PAR in CAF. RESULTS: We found higher activation level, along with increased expression of pro-invasive molecules, including u-PA, u-PAR and metalloproteinases, in CAF from patients with symptomatic MM compared to the others stages of the disease. Consistently, CAF from active MM as well as U266 cell line under the influence of medium conditioned by active MM CAF, display higher proliferative rate and invasion potential, which were significantly restrained by u-PAR gene expression inhibition. CONCLUSIONS: Our data suggest that the stimulation of u-PA/u-PAR system contributes to the activated phenotype and function of CAF during MM progression, providing a biological rationale for future targeted therapies against MM. BioMed Central 2017-03-24 /pmc/articles/PMC5366111/ /pubmed/28340565 http://dx.doi.org/10.1186/s12885-017-3183-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Ciavarella, S Laurenzana, A De Summa, S Pilato, B Chillà, A Lacalamita, R Minoia, C Margheri, F Iacobazzi, A Rana, A Merchionne, F Fibbi, G Del Rosso, M Guarini, A Tommasi, S Serratì, S u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression |
title | u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression |
title_full | u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression |
title_fullStr | u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression |
title_full_unstemmed | u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression |
title_short | u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression |
title_sort | u-par expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366111/ https://www.ncbi.nlm.nih.gov/pubmed/28340565 http://dx.doi.org/10.1186/s12885-017-3183-y |
work_keys_str_mv | AT ciavarellas uparexpressionincancerassociatedfibroblastnewacquisitionsinmultiplemyelomaprogression AT laurenzanaa uparexpressionincancerassociatedfibroblastnewacquisitionsinmultiplemyelomaprogression AT desummas uparexpressionincancerassociatedfibroblastnewacquisitionsinmultiplemyelomaprogression AT pilatob uparexpressionincancerassociatedfibroblastnewacquisitionsinmultiplemyelomaprogression AT chillaa uparexpressionincancerassociatedfibroblastnewacquisitionsinmultiplemyelomaprogression AT lacalamitar uparexpressionincancerassociatedfibroblastnewacquisitionsinmultiplemyelomaprogression AT minoiac uparexpressionincancerassociatedfibroblastnewacquisitionsinmultiplemyelomaprogression AT margherif uparexpressionincancerassociatedfibroblastnewacquisitionsinmultiplemyelomaprogression AT iacobazzia uparexpressionincancerassociatedfibroblastnewacquisitionsinmultiplemyelomaprogression AT ranaa uparexpressionincancerassociatedfibroblastnewacquisitionsinmultiplemyelomaprogression AT merchionnef uparexpressionincancerassociatedfibroblastnewacquisitionsinmultiplemyelomaprogression AT fibbig uparexpressionincancerassociatedfibroblastnewacquisitionsinmultiplemyelomaprogression AT delrossom uparexpressionincancerassociatedfibroblastnewacquisitionsinmultiplemyelomaprogression AT guarinia uparexpressionincancerassociatedfibroblastnewacquisitionsinmultiplemyelomaprogression AT tommasis uparexpressionincancerassociatedfibroblastnewacquisitionsinmultiplemyelomaprogression AT serratis uparexpressionincancerassociatedfibroblastnewacquisitionsinmultiplemyelomaprogression |